$CLS

MIONIS ROBERT sold $7.0M of CLS (indirect holdings)

MIONIS ROBERT (Chief Executive Officer) sold 18,176 indirectly-held shares of CELESTICA INC (CLS) at an average of $385.17 ($378.37–$392.11, $7.00M total) across 14 trades on 2026-06-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MIONIS ROBERT
Published Jun 18, 2026, 12:54 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
medium confidence
Mentioned
$CLS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

The disclosure provides a fresh, timestamped data point on insider activity. However, the stated Rule 10b5-1 pre-arranged plan suggests the sale schedule was predetermined, reducing the likelihood of a strong fundamental read-through.

02

Market read

A new Form 4 insider-sale print for CLS, but with 10b5-1 context that typically limits trading signal strength.

03

What to watch

Traders may over-weight the headline sale size; the key nuance is the plan being pre-arranged, which often limits interpretive edge.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-17 (after market) for a sale executed 2026-06-17

Background

The article is an SEC Form 4 insider transaction disclosure for Celestica (CLS) by CEO Mionis Robert, executed across 14 trades on 2026-06-17.

Company-level read

Ticker impact

$CLSNeutralMedium confidence
Context

Celestica CEO Mionis Robert sold $7.0M of CLS shares via a Rule 10b5-1 plan, with 18,176 shares sold on 2026-06-17.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing is primary-source and time-stamped, but it is explicitly a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary sales.

Market effects

Minimal; this is company-specific insider activity with no stated operational/regulatory change.

Minimal; no cross-border transaction or macro linkage described.

Minimal; no global supply-chain or contract details provided.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity/compensation rather than a bearish view on fundamentals.

Key entities

  • CELESTICA INC

    Issuer of the Form 4 insider sale; CEO Mionis Robert sold 18,176 shares for ~$7.0M.

  • MIONIS ROBERT

    Celestica CEO and director; sold shares via an open-market transaction under a Rule 10b5-1 plan.

Related articles

$CLSMedAI 8/10

Celestica Completes Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) said it completed its equity offering of 9,677,419 common shares at $310 per share. Including the underwriters’ option, 11,129,031 shares were sold for about $3.45 billion in gross proceeds. Net proceeds will be used for working capital, capital expenditures, and general corporate purposes.

$CLSHighAI 9/10

Celestica Falls After Pricing $3 Bln Equity Offering

Celestica Inc. (CLS) shares fell nearly 12% after the company priced a $3.0 billion public equity offering. According to the company, it sold 9.68 million common shares at $310 each, raising expected gross proceeds of $3.0 billion, and gave underwriters a 30-day option for up to 1.45 million additional shares. CLS traded around $319.48, down about $43.28.

$CLSHighAI 9/10

Why is Celestica stock sliding today?

Celestica (CLS) shares fell 13.7% after the company priced a $3 billion common stock offering at $310 per share, down from the prior close of $362.76. Celestica plans to sell about 9.68 million treasury shares, with underwriters able to buy 1.45 million more. Management said the raise supports AI compute and networking demand.

$CLSMedAI 8/10

Celestica Announces Pricing of Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) priced an equity offering of 9,677,419 common shares at $310 per share. Gross proceeds are expected at about $3.0 billion before underwriting discounts and expenses. Underwriters have a 30-day option to buy up to 1,451,612 additional shares. Net proceeds will fund working capital and capital expenditures, among other purposes. Closing is expected around Aug. 7, 2026.